KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $136,630 | -79.6% | 17,383 | -82.4% | 0.00% | -66.7% |
| Q4 2022 | $669,341 | -86.7% | 99,015 | -71.5% | 0.00% | -90.0% |
| Q3 2022 | $5,037,000 | +8.9% | 347,125 | -26.1% | 0.03% | -57.7% |
| Q2 2022 | $4,625,000 | -33.2% | 470,000 | 0.0% | 0.07% | -16.5% |
| Q1 2022 | $6,928,000 | +11.4% | 470,000 | 0.0% | 0.08% | +34.9% |
| Q4 2021 | $6,218,000 | +196.9% | 470,000 | +291.7% | 0.06% | +600.0% |
| Q3 2021 | $2,094,000 | -27.2% | 120,000 | 0.0% | 0.01% | -43.8% |
| Q2 2021 | $2,875,000 | -6.7% | 120,000 | 0.0% | 0.02% | -5.9% |
| Q1 2021 | $3,083,000 | +83.0% | 120,000 | +103.8% | 0.02% | -26.1% |
| Q1 2019 | $1,685,000 | +182.7% | 58,871 | +94.9% | 0.02% | +109.1% |
| Q4 2018 | $596,000 | – | 30,201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |